Lack of association between BST1 polymorphisms and sporadic Parkinson's disease in a Japanese population

Published:October 01, 2012DOI:https://doi.org/10.1016/j.jns.2012.09.008

      Abstract

      Several genome-wide association studies and case–control studies have investigated the relationships between single nucleotide polymorphisms (SNPs) in the BST1 gene and Parkinson's disease (PD), but the results have been inconsistent. We examined the relationships between SNPs rs11931532, rs12645693, and rs11724635 and the risk of sporadic PD in Japan. Included were 229 cases within 6 years of onset of PD as defined according to the UK PD Society Brain Bank clinical diagnostic criteria. Controls were 357 inpatients and outpatients without neurodegenerative disease. SNPs rs11931532 and rs12645693 were not significantly related to sporadic PD. Compared with a reference group of subjects with the CC genotype of SNP rs11724635, those with the AA genotype had a marginally significantly increased risk of sporadic PD: the adjusted OR was 1.57 (95% CI: 0.95–2.61, P=0.08). No significant interactions were found between BST1 SNP rs11724635 and smoking or caffeine intake with respect to sporadic PD. The current study failed to detect significant relationships between BST1 SNPs rs11931532, rs12645693, and rs11724635 and sporadic PD; however, the relationship between SNP rs11724635 and sporadic PD was of borderline significance. We do not find evidence for interactions between smoking or caffeine intake and SNP rs11724635 affecting sporadic PD.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal

      Subscribe:

      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Satake W.
        • Nakabayashi Y.
        • Mizuta I.
        • Hirota Y.
        • Ito C.
        • Kubo M.
        • et al.
        Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease.
        Nat Genet. 2009; 41: 1303-1307
        • Hamza T.H.
        • Zabetian C.P.
        • Tenesa A.
        • Laederach A.
        • Montimurro J.
        • Yearout D.
        • et al.
        Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease.
        Nat Genet. 2010; 42: 781-785
        • UK Parkinson's Disease Consortium
        • Wellcome Trust Case Control Consortium 2
        Dissection of the genetics of Parkinson's disease identifies an additional association 5′ of SNCA and multiple associated haplotypes at 17q21.
        Hum Mol Genet. 2011; 20: 345-353
        • Saad M.
        • Lesage S.
        • Saint-Pierre A.
        • Corvol J.C.
        • Zelenika D.
        • Lambert J.C.
        • et al.
        Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinson's disease in the European population.
        Hum Mol Genet. 2011; 20: 615-627
        • Chang X.L.
        • Mao X.Y.
        • Li H.H.
        • Zhang J.H.
        • Li N.N.
        • Burgunder J.M.
        • et al.
        Association of GWAS loci with PD in China.
        Am J Med Genet B Neuropsychiatr Genet. 2011; 156: 334-339
        • Tan E.K.
        • Kwok H.H.
        • Tan L.C.
        • Zhao W.T.
        • Prakash K.M.
        • Au W.L.
        • et al.
        Analysis of GWAS-linked loci in Parkinson disease reaffirms PARK16 as a susceptibility locus.
        Neurology. 2010; 75: 508-512
        • International Parkinson Disease Genomics Consortium
        Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies.
        Lancet. 2011; 377: 641-649
        • Tanaka K.
        • Miyake Y.
        • Fukushima W.
        • Sasaki S.
        • Kiyohara C.
        • Tsuboi Y.
        • et al.
        Active and passive smoking and risk of Parkinson's disease.
        Acta Neurol Scand. 2010; 122: 377-382
        • Tanaka K.
        • Miyake Y.
        • Fukushima W.
        • Sasaki S.
        • Kiyohara C.
        • Tsuboi Y.
        • et al.
        Intake of Japanese and Chinese teas reduces risk of Parkinson's disease.
        Parkinsonism Relat Disord. 2011; 17: 446-450
        • Hughes A.J.
        • Daniel S.E.
        • Kilford L.
        • Lees A.J.
        Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.
        J Neurol Neurosurg Psychiatry. 1992; 55: 181-184
        • Barrett J.C.
        • Fry B.
        • Maller J.
        • Daly M.J.
        Haploview: analysis and visualization of LD and haplotype maps.
        Bioinformatics. 2005; 21: 263-265
        • Gauderman W.J.
        Sample size requirements for matched case–control studies of gene–environment interaction.
        Stat Med. 2002; 21: 35-50
        • Andersson T.
        • Alfredsson L.
        • Källberg H.
        • Zdravkovic S.
        • Ahlbom A.
        Calculating measures of biological interaction.
        Eur J Epidemiol. 2005; 20: 575-579
        • Knol M.J.
        • VanderWeele T.J.
        • Groenwold R.H.
        • Klungel O.H.
        • Rovers M.M.
        • Grobbee D.E.
        Estimating measures of interaction on an additive scale for preventive exposures.
        Eur J Epidemiol. 2011; 26: 433-438
        • Simón-Sánchez J.
        • van Hilten J.J.
        • van de Warrenburg B.
        • Post B.
        • Berendse H.W.
        • Arepalli S.
        • et al.
        Genome-wide association study confirms extant PD risk loci among the Dutch.
        Eur J Hum Genet. 2011; 19: 655-661
        • Liu X.
        • Cheng R.
        • Verbitsky M.
        • Kisselev S.
        • Browne A.
        • Mejia-Sanatana H.
        • et al.
        Genome-wide association study identifies candidate genes for Parkinson's disease in an Ashkenazi Jewish population.
        BMC Med Genet. 2011; 12: 104
        • Lill C.M.
        • Roehr J.T.
        • McQueen M.B.
        • Kavvoura F.K.
        • Bagade S.
        • Schjeide B.M.
        • et al.
        Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: the PDGene database.
        PLoS Genet. 2012; 8: e1002548
        • Yamamoto-Katayama S.
        • Ariyoshi M.
        • Ishihara K.
        • Hirano T.
        • Jingami H.
        • Morikawa K.
        Crystallographic studies on human BST-1/CD157 with ADP-ribosyl cyclase and NAD glycohydrolase activities.
        J Mol Biol. 2002; 316: 711-723
        • Chan C.S.
        • Gertler T.S.
        • Surmeier D.J.
        Calcium homeostasis, selective vulnerability and Parkinson's disease.
        Trends Neurosci. 2009; 32: 249-256
        • Miyake Y.
        • Fukuoka Heart Study Group
        Risk factors for non-fatal acute myocardial infarction in middle-aged and older Japanese.
        Jpn Circ J. 2000; 64: 103-109